Trial Profile
Clinical trial to assess the efficacy and safety of fixed dose combination of S-Metoprolol and Telmisartan tablets in hypertension.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs S metoprolol/telmisartan (Primary) ; Metoprolol; Telmisartan
- Indications Essential hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Emcure Pharmaceuticals
- 23 Nov 2011 Status changed from recruiting to completed as reported by Clinical Trials Registry - India record.
- 28 Sep 2011 New trial record